Bosutinib Tablet, Film Coated
Product Images NDC 46708-312

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bosutinib (NDC 46708-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 Tablets (Bosutinib 100 mg)

Recommended dosage for Bosutinib Tablets is one per day, to be taken as per the accompanying prescription information. Each tablet contains 100mg of the active ingredient. This medication is intended for Oncology use only. Do not crush or cut the tablets. The package is child-resistant for safety. For more information, refer to the label for instructions.*

FDA Label Image

30 Tablets (Bosutinib 500 mg)

FDA Label Image

Bosutinib-structure.jpg (Bosutinib Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.